Pediatrix Medical Group, Inc. : Wait for a breakout
Entry price | Target | Stop-loss | Potential |
---|
$97.91 |
$105 |
$95.8 |
+7.24% |
---|
Mednax continues its bullish rally to test new highs.
Regarding the fundamentals, we note the expected increase of sales by 45% by 2015. Moreover, the analysts forecast an average target price of USD 105, which represents a potential increase of 7% compared to the current price.
Technically, the share has a bullish configuration in the mid and long-term. Prices are supported by increasing moving averages as shown by the 20-period, in daily data, and enclose the stock in a dynamic upward trend.
Therefore, investors will benefit from the signal given by the breakout of the USD 98.7 resistance to take a long position in the stock. The objective will be set near USD 105. Once the position is opened, a stop loss should be fixed under effective entry point.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.